Ginkgo biloba, a free oxygen radical scavenger, affects inflammatory mediators to diminish the occurrence of experimental myringosclerosis

Acta Oto-Laryngologica

Volumn 129, Issue 8, 2009, Pages 826-831

  Kaptan, Zeynep Kizilkaya ^a   Emir, Hatice ^a   Gocmen, Hakan ^a   Uzunkulaoglu, Hakki ^a   Karakas, Alparslan ^b   Senes, Mehmet ^b   Samim, Erdal ^a  

^a Otorhinolaryngology ENT Clinic   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anti inflammatory mediators; Antioxidants; Ginkgo biloba extract; Myringosclerosis; Rat

Indexed keywords

GINKGO BILOBA EXTRACT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRATE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EARDRUM DISEASE; ENZYME BLOOD LEVEL; MALE; MICROSCOPY; MYRINGOSCLEROSIS; MYRINGOTOMY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; EAR DISEASES; FREE RADICAL SCAVENGERS; GINKGO BILOBA; INFLAMMATION MEDIATORS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350398262     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480802468120     Document Type: Article

References (20)

1. Ö zcan C, Polat G, Görü r K, Talas DÜ , Bagdatoglu Ö , Cinel I. The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: An experimental study in myringosclerosis. Pharmacol Res 2002;/45:/6-9.
2. Uneri C, Sari M, Akboga J, Yuksel M. Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 2006;/116:/ 140-143
3. Mattsson C, Magnuson K, Hellström S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 1995;/104:/625-32.
4. Mattsson C, Marklund SL, Hellström S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 1997;/106:/ 513-518
5. Forseni MD, Bagger-Sjöback D, Hultcrantz M. A study of inflammatory mediators in the human tympanosclerotic middle ear. Arch Otolaryngol Head Neck Surg 2001;/127:/ 559-564
6. Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat. Ann Otol Rhinol Laryngol 2001;/110:/585-91.
7. Christen Y, Maixent JM. What is Ginkgo biloba extract EGb 761? An overview from molecular biology to clinical medicine. Cell Mol Biol 2002;/48:/601-11.
8. Yoshikawa T, Naito Y, Kondo M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1999;/1:/469-80.
9. Zhou YH, Yu JP, Liu YF, Teng XJ, Ming M, Lv P, et al. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-a, NF-kBp65, IL-6) in TNBS-induced colitis in rats. Mediators Inflamm 2006;/5:/1-9.
10. Mattsson C, Stierna P, Hellström S. Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 2000;/21:/804-8.
11. Smarason AK, Allman KG, Young D, Redman CW. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br J Obstet Gynaecol 1997;/104:/538-43.
12. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substance in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;/39:/ 2522-2526
13. Song JJ, Kwon SK, Cho CG, Park SW. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 2007;/71:/1287-91.
14. Huang X, Whitworth CA, Rybak LP. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 2007;/28:/828-33.
15. Wong A, Dukic-Stefonovic A, Gasic-Milenkovic J, Schinzel R, Wiesinger H, Riederer P, et al. Antiinflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci 2001;/14:/1961-7.
16. Parks RR, Huang CC, Haddad J. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 1994;/104:/ 1389-1392
17. Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, et al. The anti-oxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol 2006;/27:/882-6.
18. AkbaşY, Pata YS, Görü r K, Polat G, Polat A, Ozcan C, et al. The effect of L-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 2003;/184:/ 107-112
19. Polat S, .Ö ztü rk ö, Ü neri C, Yü ksel M, Haklar G, Bozkurt S, et al. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin E treatment. Laryngoscope 2004;/114:/720-5. (Pubitemid 38548786)
20. Sakarcan A, Sehirli O, Velioglu-Ovünc A, Ercan F, Ercan G, Gedik N, et al. Ginkgo biloba extract improves oxidative organ damage in a rat model of thermal trauma. J Burn Care Rehabil 2005;/26:/515-24. .